Tanmay Majumdar

About

Tanmay Majumdar, Ph.D.
Staff Scientist & Head
Center for Excellence in Vaccine Development
National Institute of Immunology

Career Calendar

Ph.D. in Immunology: Visva Bharati University, Santiniketan, India.

Postdoctoral Scientist: Cleveland State University, Ohio, USA

Postdoctoral Scientist: Augusta State University, Georgia, USA

Associate Professor: Bharti Vidyapeeth, Pune, India

Scientist D: University of Delhi, New Delhi, India

Employment

• National Institute of Immunology STAFF SCIENTIST AND HEAD
  2020 - Present

Education

• Visva-Bharati University MSC
  2002 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• β-catenin driven innate and metabolic reprograming in macrophages fuel T-cells dependent inflammation in Toxoplasma gondii infection: implications for therapeutic intervention
  2026 DOI: 10.21203/rs.3.rs-8453530/v1
  +Save
• Protocol for designing a peptide-based multi-epitope vaccine targeting monkeypox using reverse vaccine technology.
  STAR protocols 2025 DOI: 10.1016/j.xpro.2025.103671
  +Save
• CD36 inhibition corrects lipid-FetuinA mediated insulin secretory defects by preventing intracellular lipid accumulation and inflammation in the pancreatic beta cells.
  Biochimica et biophysica acta. Molecular basis of disease 2024 DOI: 10.1016/j.bbadis.2024.167580
  +Save
• Rational design and computational evaluation of a multi-epitope vaccine for monkeypox virus: Insights into binding stability and immunological memory
  Heliyon 2024 DOI: 10.1016/j.heliyon.2024.e36154
  +Save
• Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function
  Molecular and Cellular Endocrinology 2024 DOI: 10.1016/j.mce.2023.112112
  +Save
• Vildagliptin inhibits high fat and fetuin-A mediated DPP-4 expression, intracellular lipid accumulation and improves insulin secretory defects in pancreatic beta cells.
  Biochimica et biophysica acta. Molecular basis of disease 2024 DOI: 10.1016/j.bbadis.2024.167047
  +Save
• Enhanced expression and solubility of main protease (Mpro) of SARS-CoV-2 from E. coli.
  Protein expression and purification 2023 DOI: 10.1016/j.pep.2023.106337
  +Save
• Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections.
  International journal of biological macromolecules 2023 DOI: 10.1016/j.ijbiomac.2023.125444
  +Save
• FFA-Fetuin-A regulates DPP-IV expression in pancreatic beta cells through TLR4-NFkB pathway
  Biochemical and Biophysical Research Communications 2023 DOI: 10.1016/j.bbrc.2023.01.070
  +Save
• Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2.
  PLoS computational biology 2021 DOI: 10.1371/journal.pcbi.1009384
  +Save